Investor Presentaiton
Strong growth in operating cashflows
A$m
H1 FY22
H1 FY21
Growth
Statutory operating cash flow
80.0
111.7
(28%)
Add: IPO deal costs in operating cash flow
20.9
(0.0)
Add: Net finance costs paid
(0.0)
(0.0)
Add: Net income taxes paid
37.5
5.7
Pro forma operating cash flow¹
138.4
117.4
18%
Pro forma EBITDA²
138.8
119.1
17%
Pro forma EBITDA cash conversion³
100%
98%
For personal use only
Statutory cash flow
Operating cash flow
Investing cash flow
Financing cash flow
Net increase / (decrease) in cash
Opening cash (including FX differences)
Closing cash
14
|H1 FY22 Results Presentation
80.0
111.7
(113.6)
(31.1)
148.1
(46.4)
114.5
34.2
106.8
221.3
28.9
63.1
.
Pro forma operating cashflow up 18% to $138.4m
Underpinned by EBITDA growth in H1 FY22
•
Investing cashflow of $113.6m supports growth strategy
Acquisitions of Generation Health, DWFS, Early Start
Australia, MyIntegra and Mobility - $76.4m
Capex driven by Restart mobilisation, IT fleet and
security upgrades - $37.2m
Financing cash flows of $148.1m
Includes proceeds of $343.5m from the IPO and debt
repayments of $161.9m
Interest payments down $10.6m following July 2021
debt refinance, IPO and debt repayment
(1) pro forma operating cash (statutory operating cash adding back cash income tax paid, net finance costs and one-off IPO advisor fees)
(2) Earnings before interest, tax, depreciation and amortization, refer slide 24 for a reconciliation of pro forma EBITDA
(3) Cash conversion reflects pro forma operating cash (statutory operating cash adding back cash income tax paid, net finance costs and one-off IPO advisor
fees) divided by pro forma EBITDA.
APM
enabling better livesView entire presentation